Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses

NCT07408583 is registered in ClinicalTrials.gov with Agnieszka Czechowicz as lead sponsor.

NCT NCT07408583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07408583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II, Non-Randomized Study of the Safety and Efficacy of In Utero Hematopoietic Stem Cell Transplantation for the Treatment of Fanconi Anemia in Affected Fetuses
Lead sponsor
Agnieszka Czechowicz
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
January 31, 2028
Completion date
July 31, 2033
Enrollment
12 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hypoplastic, congenital, bone marrow failure disorders, cancer predisposition syndrome, congenital bone marrow failure syndromes, congenital, hereditary, and neonatal diseases and abnormalities, dna repair-deficiency disorders, fanconi anemia, genetic diseases, inborn